• Clinical Evidence

Improving IV Insulin Administration in a Community Hospital

Setting: 207-bed not-for-profit community hospital.

Objective

This study compares glycemic outcomes with a traditional paper protocol to a computerized glucose management system (EndoTool) for patients receiving intravenous insulin.

Setting

207-bed not-for-profit community hospital.

Results

  • Incidence of hypoglycemia <70 mg/dL decreased 89% with EndoTool, from 6.9% to 0.76% of blood glucose readings
  • Incidence of hypoglycemia <40 mg/dL was .01% of blood glucose readings with EndoTool.
  • Incidence of hyperglycemia >180 mg/dL decreased 54% with EndoTool, from 26.3% to 12.1% of blood glucose readings, and incidence >300 mg/dL decreased 68%, from 4.9% to 1.55% of blood glucose readings.
  • Percentage of blood glucose readings in target increased 35% with EndoTool, from 63.6% to 86.1%.

Conclusions

Use of a computerized glucose management system (EndoTool) achieves substantially better glucose control than a traditional paper protocol, with lower incidence of both hypoglycemia and hyperglycemia and a greater percentage of blood glucose readings in target.
Objective

This study compares glycemic outcomes with a traditional paper protocol to a computerized glucose management system (EndoTool) for patients receiving intravenous insulin.

Setting

207-bed not-for-profit community hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL decreased 89% with EndoTool, from 6.9% to 0.76% of blood glucose readings
  • Incidence of hypoglycemia <40 mg/dL was .01% of blood glucose readings with EndoTool.
  • Incidence of hyperglycemia >180 mg/dL decreased 54% with EndoTool, from 26.3% to 12.1% of blood glucose readings, and incidence >300 mg/dL decreased 68%, from 4.9% to 1.55% of blood glucose readings.
  • Percentage of blood glucose readings in target increased 35% with EndoTool, from 63.6% to 86.1%.
Conclusions

Use of a computerized glucose management system (EndoTool) achieves substantially better glucose control than a traditional paper protocol, with lower incidence of both hypoglycemia and hyperglycemia and a greater percentage of blood glucose readings in target.

References

Authors

Michael Magee.

Source

Published in Journal of Visualized Experiments (Medicine), Issue 64, pe3705.

Year

2012

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This study compares glycemic outcomes with a traditional paper protocol to a computerized glucose management system (EndoTool) for patients receiving intravenous insulin.

Setting

207-bed not-for-profit community hospital.

Results
  • Incidence of hypoglycemia <70 mg/dL decreased 89% with EndoTool, from 6.9% to 0.76% of blood glucose readings
  • Incidence of hypoglycemia <40 mg/dL was .01% of blood glucose readings with EndoTool.
  • Incidence of hyperglycemia >180 mg/dL decreased 54% with EndoTool, from 26.3% to 12.1% of blood glucose readings, and incidence >300 mg/dL decreased 68%, from 4.9% to 1.55% of blood glucose readings.
  • Percentage of blood glucose readings in target increased 35% with EndoTool, from 63.6% to 86.1%.
Conclusions

Use of a computerized glucose management system (EndoTool) achieves substantially better glucose control than a traditional paper protocol, with lower incidence of both hypoglycemia and hyperglycemia and a greater percentage of blood glucose readings in target.

References

Authors

Michael Magee.

Source

Published in Journal of Visualized Experiments (Medicine), Issue 64, pe3705.

Year

2012

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Image
  • Clinical Evidence

How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M

How Corewell Health Reduced LOS for DKA Patients, Slashing Costs by Almost $1M

The objective of this study was to evaluate the impact of EndoTool IV insulin dosing software on mortality, length of stay, readmission rates, and cost of care for patients treated for Diabetic Ketoacidosis (DKA) at Corewell Health West.
Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.